Trius Therapeutics is a biopharmaceutical company focused
on the discovery, development and commercialization
of innovative antibiotics for serious, life-threatening infections
Trius Therapeutics Announces Publication of Antibiotic Safety Study in Antimicrobial Agents and Chemotherapy »
Trius Appoints Matthew Onaitis as General Counsel »